Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more
Rethinking the Architecture of Adverse Event Processing
Deploying AI agents to handle data collection, coding, medical review, and quality-checking makes signal management autonomous at the processing stage. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

VectorBuilder, Lir Partner to Engineer More Manufacturable AAV Capsids
Thursday, August 20, 2026
VectorBuilder and Lir Therapeutics have formed a strategic collaboration to develop adeno-associated virus capsids designed to combine biological ... read more
Charles River, Medigen Partner on Multivalent Enterovirus Vaccine
Thursday, August 20, 2026
Charles River Laboratories International and Medigen Vaccine Biologics Corp. have formed a collaboration to support development of Medigen’s next-... read more
Cytovance Adds Standalone Analytical Services
Wednesday, August 19, 2026
Cytovance Biologics has launched standalone analytical services for biopharmaceutical companies, allowing clients to access analytical testing without... read more
Piramal Pharma Takes Controlling Stake in Yapan Bio
Wednesday, August 19, 2026
Piramal Pharma Ltd. has completed the acquisition of an additional 40.67% stake in Hyderabad-based biologics contract development and manufacturing ... read more
Clinilabs Names Laura Shannon CEO; Founder Gary Zammit Becomes Executive Chair
Tuesday, August 18, 2026
Clinilabs has appointed biopharma executive Laura Shannon as chief executive officer and promoted founder Gary Zammit, Ph.D., to executive chairperson... read more